News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Bio NC
TranS1 Announces Participation in Two Investor Conferences in June 2011
June 14, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WILMINGTON, N.C., June 13, 2011 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today it will participate in two investor conferences in June.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
Obesity
Zealand dips as Boehringer Ingelheim-partnered weight loss drug fails to impress—again
October 1, 2026
·
2 min read
·
Heather McKenzie
Obesity
Superior weight loss, blood sugar control propel Lilly’s amylin-GIP/GLP-1 combo into Phase 3
September 30, 2026
·
3 min read
·
Heather McKenzie
Psychedelics
Psychedelic therapies ride wave of public favor into FDA hearing
September 14, 2026
·
3 min read
·
Michael Gibney
FDA
Biotech leaders call for streamlining of INDs as FDA’s TrialBlazer rolls out
August 3, 2026
·
9 min read
·
Jef Akst